Oxaliplatin-Fluoropyrimidine Combination (XELOX) Therapy Does Not Affect Plasma Amino Acid Levels and Plasma Markers of Oxidative Stress in Colorectal Cancer Surgery Patients: A Pilot Study

Oxaliplatin-Fluoropyrimidine Combination (XELOX) Therapy Does Not Affect Plasma Amino Acid Levels and Plasma Markers of Oxidative Stress in Colorectal Cancer Surgery Patients: A Pilot Study

Chemotherapy for colorectal cancer may lower muscle protein synthesis and increase oxidative stress. We hypothesize that chemotherapy may worsen plasma amino acids (AAs) and markers of oxidative stress (MOS). Therefore, this study aimed to document plasma AAs and MOS before, during and after chemoth...

Full description

Bibliographic Details
Main Authors: Roberto Aquilani, Silvia Brugnatelli, Maurizia Dossena, Roberto Maestri, Sara Delfanti, Daniela Buonocore, Federica Boschi, Elena Simeti, Anna Maria Condino, Manuela Verri
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Nutrients
Subjects:
colorectal cancer
surgery
chemotherapy
plasma amino acids
oxidative stress
Online Access:https://www.mdpi.com/2072-6643/11/11/2667

Internet

https://www.mdpi.com/2072-6643/11/11/2667

Similar Items